# Safety and Immunogenicity of Influenza H9 Vaccine in Humans

> **NCT00814229** · PHASE1 · COMPLETED · sponsor: **University Hospitals, Leicester** · enrollment: 353 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** H9N2 whole virus vaccine, IM, 1.5microg
- **BIOLOGICAL:** H9N2 whole virus vaccine, IM, 5microg
- **BIOLOGICAL:** H9N2 whole virus vaccine vaccine, IM, 15microg
- **BIOLOGICAL:** H9N2 whole virus vaccine, IM, 45microg
- **BIOLOGICAL:** H9N2 whole virus vaccine, alum, IM, 1.5microg
- **BIOLOGICAL:** H9N2 whole virus, alum, IM, 5microg
- **BIOLOGICAL:** H9N2 vaccine, whole virus, alum, IM, 15 microg
- **BIOLOGICAL:** H9N2 vaccine, whole virus, alum, IM, 45microg
- **BIOLOGICAL:** H9N2 virosome vaccine, IM, 1.5microg
- **BIOLOGICAL:** H9N2 virosomal vaccine, IM, 5microg
- **BIOLOGICAL:** H9N2 virosomal vaccine, IM, 15microg
- **BIOLOGICAL:** H9N2 virosomal vaccine, IM, 45microg
- **BIOLOGICAL:** H9N2 whole virus vaccine, ID, 5microg
- **BIOLOGICAL:** H9N2 whole virus vaccine, ID, 15microg

## Key facts

- **NCT ID:** NCT00814229
- **Lead sponsor:** University Hospitals, Leicester
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2008-01
- **Final completion:** 2008-09
- **Target enrollment:** 353 (ACTUAL)
- **Last updated:** 2009-07-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00814229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00814229, "Safety and Immunogenicity of Influenza H9 Vaccine in Humans". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00814229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*